Yan Shujie, Lou Song, Zhu Jiade, Liu Sheng, Zhao Yu, Song Yunhu, Wang Hui, Ji Bingyang
Department of Cardiopulmonary Bypass, Fuwai Hospital, Chinese Academy of Medical science and Peking Union Medical College, Beijing, China.
Department of Cardiovascular surgery, Fuwai Hospital, Chinese Academy of Medical science and Peking Union Medical College, Beijing, China.
Perfusion. 2019 Sep;34(6):475-481. doi: 10.1177/0267659119831518. Epub 2019 Mar 1.
The aim of this retrospective study was to review and report short-term and mid-term outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at our institute in the recent 2 years and to describe perfusion strategy.
A total of 58 consecutive patients with chronic thromboembolic pulmonary hypertension underwent pulmonary endarterectomy under deep hypothermia circulatory arrest with an established perfusion practice between November 2015 and December 2017. Peri-operative data and patients' outcome were retrospectively analyzed.
Mean pulmonary artery pressure was decreased (49 (40-56) mmHg vs 27 (20-31) mmHg, p < 0.001), and pulmonary vascular resistance (724 (538-1108) vs 206 (141-284) dyn second cm, p < 0.001) improved significantly after surgery. In-hospital mortality was 1.7% and postoperative complication rate was 27.6%. Antipsychotic medication of olanzapine was prescribed for 36 patients (62.1%), which was independently related to total deep hypothermic circulatory arrest time, postoperative blood potassium concentration, and hematocrit. The majority of patients recovered uneventfully with good mid-term cardiac function (New York Heart Association I-II: 98.1%) and neurological outcome (Glasgow Outcome Scale-Extended Upper Good Recovery: 74.1% and Lower Good Recovery: 20.3%). Mid-term neurological outcome was associated with post-pulmonary endarterectomy antipsychotic medication.
Short-term and mid-term outcome after pulmonary endarterectomy was comparable to high-volume centers. Incidence of post-pulmonary endarterectomy delirium was relatively high and associated with mid-term neurological outcome. Total deep hypothermic circulatory arrest time, postoperative blood potassium concentration, and hematocrit were independent risk factors of postoperative olanzapine medication. More efforts and further research are required to optimize the neuroprotection of perfusion practice.
本回顾性研究旨在回顾并报告我院近2年慢性血栓栓塞性肺动脉高压患者接受肺动脉内膜剥脱术的短期和中期结果,并描述灌注策略。
2015年11月至2017年12月期间,共有58例连续性慢性血栓栓塞性肺动脉高压患者在深度低温循环停搏下接受肺动脉内膜剥脱术,并采用既定的灌注方法。对围手术期数据和患者结局进行回顾性分析。
术后平均肺动脉压显著降低(49(40 - 56)mmHg对27(20 - 31)mmHg,p < 0.001),肺血管阻力显著改善(724(538 - 1108)对206(141 - 284)dyn·秒/cm,p < 0.001)。住院死亡率为1.7%,术后并发症发生率为27.6%。36例患者(62.1%)使用了奥氮平抗精神病药物,这与总低温循环停搏时间、术后血钾浓度和血细胞比容独立相关。大多数患者恢复顺利,中期心功能良好(纽约心脏协会I - II级:98.1%),神经功能结局良好(格拉斯哥扩展预后量表 - 上部良好恢复:74.1%,下部良好恢复:20.3%)。中期神经功能结局与肺动脉内膜剥脱术后抗精神病药物使用有关。
肺动脉内膜剥脱术后的短期和中期结果与大型中心相当。肺动脉内膜剥脱术后谵妄的发生率相对较高,且与中期神经功能结局相关。总低温循环停搏时间、术后血钾浓度和血细胞比容是术后使用奥氮平药物的独立危险因素。需要更多努力和进一步研究来优化灌注方法的神经保护作用。